Initiation of the inflammatory response begins with the surgical placement of an implant that stimulates bone remodeling. The occurrence of crestal bone loss during submerged healing affects the prognosis of an implant. Hence, this study was conducted to estimate the early implant bone loss during the preprosthetic phase on bone level implants placed equicrestally. This retrospective observational study included evaluation of crestal bone loss around 271 two-piece implants placed in 149 patients from the archived postsurgical (P1) and preprosthetic (P2) digital orthopantomographic records using MicroDicom software. The outcome was categorized based on (1) sex (male or female), (2) time of implant placement (immediate [I] vs conventional [D]), (3) duration of healing period before loading (conventional [T1] vs delayed [T2]), (4) region of implant placement (maxilla [M1] vs mandible [M2]), and (5) site of implant placement (anterior [A] vs posterior [P]). To find the significant difference between the bivariate samples in the independent groups, an unpaired sample t test was used. The average marginal bone loss during the healing phase was 0.56 ± 0.573 mm in the mesial region and 0.44 ± 0.549 mm in the distal region of the implant, with a statistically significant difference (P < .01). There was no statistically significant difference in crestal bone level with the (1) sex of the patient (male or female), (2) type of implant placement (I or D), (3) time of implant loading (T1 or T2), (4) region of implant placement (M1 or M2), or (5) site of implant in the arch (A or P) (P > .05). An average of 0.50 mm crestal bone loss occurred in the peri-implant region during the preprosthetic phase. We found that the delayed placement of an implant and a delay in the healing period would further increase the early implant bone loss. The difference in the healing period did not alter the outcome of the study.

You do not currently have access to this content.